Recombinant Tick-Borne Encephalitis Virus NS1 Protein, His-tagged

• Cat.No.: TIC-588
• Product Overview: Tick-Borne Encephalitis Virus NS1 protein is produced entirely from human cell lines using state-of-the-art expression techniques, the same approach which NAC used to develop its well-received Dengue Virus NS1 serotypes and West Nile Virus NS1 protein.

Specification

• Tag: His
• Background: The Tick-borne encephalitis virus (TBEV) is a Flavivirus which is transmitted to humans through a bite from an infected tick. Tick-borne encephalitis (TBE) is endemic in Europe and Asia with an average of 8,500 cases per year in Europe (https://wwwnc.cdc.gov/travel/page/yellowbook-home-2014/). TBE infected patients typically present with influenza-like symptoms and the disease is neuroinvasive often manifesting as meningitis, encephalitis or meningoencephalitis. Long-lasting or permanent neuropsychiatric sequelae are reported in 10 to 20% of patients.
• Purity: >90% by SDS-PAGE
• Sequence Strain: Neudoerfl
• Formulation: DPBS pH 7.4,0.2μm filter sterilised.
• Stability: At +4 centigrade: 1 week.
  At -80 centigrade: 1 year.
• Freezing: Can be frozen, but avoid multiple freeze/thaw cycles.
• Storage: Short Term Storage: +2 centigrade to +8 centigrade
  Long Term Storage: -20 centigrade to -80 centigrade
• Concentration: 0.524 mg/mL
• Notes: This product is intended for research and manufacturing uses only. It is not a diagnostic device. The user assumes all responsibility for care, custody and control of the material, including its disposal, in accordance with all regulations.
• Type: Recombinant
• ClassID 1: Infectious Disease

Gene Information

• Synonyms: Tick-Borne Encephalitis Virus NS1